| Application no. and date | 16167355.3 (espacenet) (Federated) (European Patent Register), 20111215 | | Patent/reg. no. and date | DK/EP 3121171, 20180815 | | Publication date | 20170125 | | Priority no. and date | US 201061424194 P, 20101217 | | EP pub. no. and date |
EP 3121171 20170125 | | Effective date | | | Applicant/owner | NOVARTIS AG, Lichtstrasse 35
4056 Basel, CH | | Applicant ref. no. | SH/GP/157559 | | Inventor | FENG, Lili, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936-1080, US,
GONG, Baoqing, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936-1080, US,
KARPINSKI, Piotr H., Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936-1080, US,
WAYKOLE, Liladhar Murlidhar, Novartis Pharmaceuticals Corporation
One Health Plaza
East Hanover, New Jersey 07936-1080, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/506 (2006.01) , A61P 35/00 (2006.01) , C07D 401/12 (2006.01) | | Title | Krystallinske former af 5-chlor-N2-(2-isopropoxy-5-methyl-4-piperidin-4-yl-phenyl)-N4[2-(propan-2-sulfonyl)-phenyl]-pyrimidin-2,4-diamin | | Int. application no. | | | Int. publication no. | | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
